P0810 : Sofosbuvir and daclatasvir combined treatment for chronic hepatitis C: First-year efficacy and safety data in a real-life setting

Autor:	Andre-Jean Remy, Arnaud Pauwels, Jean-Pierre Arpurt, S. de Montigny-Lenhardt, E. Maringe, J.-H. Salloum, Bruno Lesgourgues, E. Gagea, Alexandre Pariente, H. Labadie, H. Hagège, Xavier Causse, Christophe Renou, Isabelle Rosa-Hézode, Vincent Jouannaud, Gilles Macaigne, Ramuntxo Arotcarena, F. Bourhis, Hortensia Lison
Rok vydání:	2015
Předmět:	Pediatrics medicine.medical_specialty Daclatasvir Combined treatment Hepatology Sofosbuvir Chronic hepatitis business.industry medicine Real life setting business medicine.drug
Zdroj:	Journal of Hepatology. 62:S639
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(15)31013-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::718563b54712d76ee58d7a25842af99d https://doi.org/10.1016/s0168-8278(15)31013-8 Zobrazit plný text záznamu Full Text from ScienceDirect